U.S. News
A New Battle Over Abortion Pill Safety Is Heating Up in Congress

Clear Facts
- Republican Sen. Josh Hawley introduces legislation to revoke FDA approval for mifepristone abortion pill.
- Bill enables harmed women to sue greedy foreign manufacturers profiting billions from dangerous drug.
- One in ten women suffers serious adverse events per April 2025 EPPC insurance data study.
Sen. Hawley announced the bill Wednesday amid Trump administration delays on mifepristone safety review.
Women shared harrowing stories of complications including emergency room visits for life-threatening infections and PTSD.
“Only Congress can address this situation,” Hawley declared at the press conference.
“It is time for Congress to ban the use of mifepristone for abortion.”
“And it’s time for Congress to give the victims, the survivors, many of whom are here today, the right to recover against this company that has inflicted harm on them solely for the purpose of making profits.”
Elizabeth Gillette described pulling out a formed embryonic sac after severe bleeding: “There wasn’t enough towels or anything else to mop the blood as it pooled on the floor around the toilet and in the tub.”
“When I felt pressure, I felt in between my legs and I pulled out a perfectly formed embryonic sac, with my baby floating inside it, with recognizable eyes, limbs and ear buds…They didn’t tell me that there was any complications regarding this pill.”
Trump DOJ filed to pause Missouri lawsuit seeking abortion pill restrictions; pro-life leaders call it siding with abortion industry.
SBA Pro-Life America’s Marjorie Dannenfelser said administration efforts hit a dead end: “We are waiting. We are waiting. We are waiting.”
Rosalie Markezich, coerced into taking mailed pill, demands FDA accountability: “Women deserve better and their stories will be heard.”
Hawley’s bill blocks doctors from prescribing mifepristone legally and empowers victims against foreign corporations.
Support Sen. Hawley’s stand against Big Abortion endangering women and unborn for profits.
Let us know what you think, please share your thoughts in the comments below.